Mental Health & Depression: 61 new trials, 3 Phase 3, 3,252 recruiting, May 4–11, 3628 off-label use reports.
Doctiplus - We are allways here!
Doctiplus - We are allways here!
Mental Health & Depression: 61 new trials, 3 Phase 3, 3,252 recruiting, May 4–11, 3628 off-label use reports.
Cancer & Oncology: 156 new trials, 18,738 recruiting, 3,407 papers published May 4–11, Off Label Use tops 8,516 reports.
Diabetes Type 2: 35 new trials, 1,980 recruiting, 1,406 papers published. Off Label Use tops adverse reports at 10,229. May 4–11.
Heart Disease & Cardiovascular: 112 new trials, 8,669 recruiting, 1,952 papers published May 4–11, Fatigue tops adverse reports at 6,625.
Dementia & Alzheimer’s: 13 new trials, 936 recruiting, 1,371 papers published, 628 death reports. May 4–11.
Mental Health & Depression: 55 new trials, 3,244 recruiting, 2,293 papers. Off Label Use tops adverse reports at 3,509. April 27 – May 4.
Cancer & Oncology: 187 new trials, 18,692 recruiting, 7,229 papers published, April 27 – May 4, Off Label Use tops 8,459 reports
Diabetes Type 2: 29 new trials, 1,980 recruiting, 2,112 papers published. Off-label use tops 9,837 reports. April 27–May 4.
Heart Disease & Cardiovascular: 98 new trials, 8,656 recruiting, 3,915 papers published. Fatigue reported 6,351 times. April 27 – May 4.
Dementia & Alzheimer’s: 6 new trials, 936 recruiting, 1,644 papers published, 619 death reports, April 27 – May 4